Related Experiment Videos
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings
Blood
|June 1, 1987
Summary
Intermediate lymphocytic lymphoma exhibits a distinct immunophenotype and common chromosomal abnormalities, particularly involving chromosomes 11 and 12. These findings support its classification as a separate lymphoma category.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Intermediate lymphocytic lymphoma (ILL) is a type of non-Hodgkin lymphoma.
- Understanding its immunophenotypic and cytogenetic profile is crucial for accurate classification and diagnosis.
Purpose of the Study:
- To conduct a detailed immunohistologic and cytogenetic analysis of 12 cases of intermediate lymphocytic lymphoma.
- To define the characteristic immunophenotype and chromosomal abnormalities associated with ILL.
- To evaluate the relationship between ILL and other lymphocytic lymphomas.
Main Methods:
- Immunohistologic analysis using a panel of antibodies to define cell surface markers.
- Cytogenetic analysis to identify clonal chromosome abnormalities.
- Comparison of findings with established criteria for lymphocytic lymphomas.
Main Results:
- The characteristic immunophenotype included surface IgM and IgD positivity, with specific expression of BA1, B1, B4, Leu 14, Leu 1, and HLA-DR, and negativity for B2 and common acute lymphocytic leukemia (CALLA) antigen.
- Clonal chromosome abnormalities were found in 10 out of 12 cases.
- Abnormalities of chromosomes 11 or 12 were present in 9 cases, including translocations involving 11q and 14q32, trisomy 12, and abnormalities of 12q. One case showed a 7;9 translocation.
Conclusions:
- The immunophenotypic and cytogenetic findings suggest a close lineage relationship between intermediate lymphocytic lymphoma and small lymphocytic lymphoma/chronic lymphocytic leukemia.
- Distinct clinical, cytologic, and architectural features warrant the classification of intermediate lymphocytic lymphoma as a separate category within the International Working Formulation.
- This study provides key diagnostic markers for intermediate lymphocytic lymphoma, aiding in its differentiation from other lymphoid malignancies.